Exiqon A/S provides life science research products worldwide. It operates through two segments, Life Sciences and Diagnostics. The company’s products serve as a platform for the development of molecular diagnostic tests. It develops molecular diagnostic tests in collaboration with pharmaceutical and diagnostic companies. The company’s products include miRCURY RNA isolation kits; microRNA Array system, a system for global microRNA expression profiling; microRNA qPCR system, which enables microRNA expression profiling; microRNA detection probes that are used for the ultra-sensitive, and detection of microRNAs by Northern blot analysis and in situ hybridization; and microRNA inhibitor and target site blockers for functional analysis. It also offers microarrays capture probes for expression analysis of splice variants, small RNAs, and mRNA; qPCR assays for mRNA and ncRNA; RNA detection probes for in situ hybridization and Northern blot; and longRNA GapmeR, which are antisense oligonucleotides used for the inhibition of mRNA and lncRNA function. In addition, the company provides oligonucleotides and microarray capture probes to detect single nucleotide polymorphism; FISH probes to detect chromosomal DNA sequences; custom LNA oligonucleotides; LNA phosphoramidites for the synthesis of LNA containing oligonucleotides; and A2-quencher phosphoramidite, a dark quencher for real-time PCR probes. Further, it offers RNA isolation services for the sample types, including exosome isolation, blood derived serum, plasma and other bio-fluids, clinical FFPE and fresh frozen tissues, and cell lines; MicroRNA array and profiling services; microRNA and Small RNA sequencing services; microRNA in situ hybridization screening services; and custom pharma services, such as biomarker discovery, validation experiments, and others. The company markets its research products through direct sales, distributors, and the Web. Exiqon A/S was founded in 1995 and is headquartered in Vedbæk, Denmark.
(EXQ:Copenhagen Stock Exchange)
Phone: 45 45 66 08 88
Fax: 45 45 66 18 88www.exiqon.com
|Fluidigm Corp||$5.86 USD||-0.165|
|Foundation Medicine Inc||$14.12 USD||-0.02|
|HTG Molecular Diagnostics Inc||$2.32 USD||-0.155|
|NanoString Technologies Inc||$11.72 USD||-0.17|
|WaferGen Bio-systems Inc||$0.61 USD||-0.0016|
|View Industry Companies|
Sponsored Financial Commentaries
To contact EXIQON A/S, please visit www.exiqon.com. Company data is provided by Capital IQ. Please use this form to report any data issues.